Plain-English translation of NCT07080944 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether sentinel lymph node biopsy—a simpler, less invasive way to check lymph nodes for cancer—can be safely used in women with advanced inflammatory breast cancer after they've completed chemotherapy. Traditionally, doctors thought this approach was too risky for women with very advanced cancer, but this study wants to see if it actually works well and is safe for these patients.
Women with advanced inflammatory breast cancer have historically needed more extensive lymph node surgery, which can cause more side effects and longer recovery times. This trial exists to see whether the gentler approach could work just as well, potentially sparing patients from unnecessary extensive surgery.
You likely qualify if…
You likely don't qualify if…
You would have already completed chemotherapy before enrolling. On the day of surgery, doctors would use a special dye and imaging technique to identify and remove only the sentinel lymph nodes (the first nodes where cancer typically spreads). Depending on what they find, you may or may not need additional lymph node removal. After surgery, you would be followed long-term to see how well this approach works for you and to monitor your health outcomes over time.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy